Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder
Clinical trial NCT02484456 · COMPLETED
Trial details
- NCT number
- NCT02484456
- Sponsor
- National Institute of Mental Health (NIMH)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-14
- Primary completion
- 2019-02-21
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.